SXTC icon

China SXT Pharmaceuticals
SXTC

Overview Fund Activity

5 hedge funds and large institutions have $139K invested in China SXT Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
1
Virtu Financial
New York
$48K
2
TSS
2
Two Sigma Securities
New York
$24.2K
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$24K
4
Millennium Management
4
Millennium Management
New York
$37K
5
UBS Group
5
UBS Group
Switzerland
$5.73K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
HF
2
HRT Financial
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
VF
1
Virtu Financial
New York
$48K 89,157 +89,157 New
Millennium Management
2
Millennium Management
New York
$37K 67,648 +21,963 +48%
TSS
3
Two Sigma Securities
New York
$24.2K 44,650 +44,650 New
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$24K 45,520 +45,520 New
UBS Group
5
UBS Group
Switzerland
$5.73K 10,616 +2,891 +37%
Renaissance Technologies
6
Renaissance Technologies
New York
– – -21,572 Closed
HF
7
HRT Financial
New York
– – -10,870 Closed
HI
8
Hudock Inc
Pennsylvania
– – -300 Closed
CFGS
9
Concourse Financial Group Securities
Alabama
– – – –